Dysmenorrhea Treatment Market, Global Outlook and Forecast 2024-2031

Report ID: 1066816 | Published Date: Jan 2025 | No. of Page: 69 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Dysmenorrhea Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Dysmenorrhea Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Dysmenorrhea Treatment Overall Market Size
    2.1 Global Dysmenorrhea Treatment Market Size: 2021 VS 2028
    2.2 Global Dysmenorrhea Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Dysmenorrhea Treatment Players in Global Market
    3.2 Top Global Dysmenorrhea Treatment Companies Ranked by Revenue
    3.3 Global Dysmenorrhea Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Dysmenorrhea Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Dysmenorrhea Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Dysmenorrhea Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Dysmenorrhea Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Dysmenorrhea Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Dysmenorrhea Treatment Market Size Markets, 2021 & 2028
        4.1.2 Pain Relievers
        4.1.3 Hormonal Therapy
        4.1.4 Surgery
    4.2 By Type - Global Dysmenorrhea Treatment Revenue & Forecasts
        4.2.1 By Type - Global Dysmenorrhea Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Dysmenorrhea Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Dysmenorrhea Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Dysmenorrhea Treatment Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Research Centers
        5.1.5 Others
    5.2 By Application - Global Dysmenorrhea Treatment Revenue & Forecasts
        5.2.1 By Application - Global Dysmenorrhea Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Dysmenorrhea Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Dysmenorrhea Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Dysmenorrhea Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Dysmenorrhea Treatment Revenue & Forecasts
        6.2.1 By Region - Global Dysmenorrhea Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Dysmenorrhea Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Dysmenorrhea Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Dysmenorrhea Treatment Revenue, 2017-2028
        6.3.2 US Dysmenorrhea Treatment Market Size, 2017-2028
        6.3.3 Canada Dysmenorrhea Treatment Market Size, 2017-2028
        6.3.4 Mexico Dysmenorrhea Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Dysmenorrhea Treatment Revenue, 2017-2028
        6.4.2 Germany Dysmenorrhea Treatment Market Size, 2017-2028
        6.4.3 France Dysmenorrhea Treatment Market Size, 2017-2028
        6.4.4 U.K. Dysmenorrhea Treatment Market Size, 2017-2028
        6.4.5 Italy Dysmenorrhea Treatment Market Size, 2017-2028
        6.4.6 Russia Dysmenorrhea Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Dysmenorrhea Treatment Market Size, 2017-2028
        6.4.8 Benelux Dysmenorrhea Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Dysmenorrhea Treatment Revenue, 2017-2028
        6.5.2 China Dysmenorrhea Treatment Market Size, 2017-2028
        6.5.3 Japan Dysmenorrhea Treatment Market Size, 2017-2028
        6.5.4 South Korea Dysmenorrhea Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Dysmenorrhea Treatment Market Size, 2017-2028
        6.5.6 India Dysmenorrhea Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Dysmenorrhea Treatment Revenue, 2017-2028
        6.6.2 Brazil Dysmenorrhea Treatment Market Size, 2017-2028
        6.6.3 Argentina Dysmenorrhea Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Dysmenorrhea Treatment Revenue, 2017-2028
        6.7.2 Turkey Dysmenorrhea Treatment Market Size, 2017-2028
        6.7.3 Israel Dysmenorrhea Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Dysmenorrhea Treatment Market Size, 2017-2028
        6.7.5 UAE Dysmenorrhea Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Merck & Co.
        7.1.1 Merck & Co. Corporate Summary
        7.1.2 Merck & Co. Business Overview
        7.1.3 Merck & Co. Dysmenorrhea Treatment Major Product Offerings
        7.1.4 Merck & Co. Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.1.5 Merck & Co. Key News
    7.2 Novartis AG
        7.2.1 Novartis AG Corporate Summary
        7.2.2 Novartis AG Business Overview
        7.2.3 Novartis AG Dysmenorrhea Treatment Major Product Offerings
        7.2.4 Novartis AG Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.2.5 Novartis AG Key News
    7.3 Bayer
        7.3.1 Bayer Corporate Summary
        7.3.2 Bayer Business Overview
        7.3.3 Bayer Dysmenorrhea Treatment Major Product Offerings
        7.3.4 Bayer Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.3.5 Bayer Key News
    7.4 Abbott Laboratories
        7.4.1 Abbott Laboratories Corporate Summary
        7.4.2 Abbott Laboratories Business Overview
        7.4.3 Abbott Laboratories Dysmenorrhea Treatment Major Product Offerings
        7.4.4 Abbott Laboratories Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.4.5 Abbott Laboratories Key News
    7.5 Pfizer
        7.5.1 Pfizer Corporate Summary
        7.5.2 Pfizer Business Overview
        7.5.3 Pfizer Dysmenorrhea Treatment Major Product Offerings
        7.5.4 Pfizer Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.5.5 Pfizer Key News
    7.6 Roche
        7.6.1 Roche Corporate Summary
        7.6.2 Roche Business Overview
        7.6.3 Roche Dysmenorrhea Treatment Major Product Offerings
        7.6.4 Roche Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.6.5 Roche Key News
    7.7 TAJ Pharma
        7.7.1 TAJ Pharma Corporate Summary
        7.7.2 TAJ Pharma Business Overview
        7.7.3 TAJ Pharma Dysmenorrhea Treatment Major Product Offerings
        7.7.4 TAJ Pharma Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.7.5 TAJ Pharma Key News
    7.8 Mylan Pharmaceuticals
        7.8.1 Mylan Pharmaceuticals Corporate Summary
        7.8.2 Mylan Pharmaceuticals Business Overview
        7.8.3 Mylan Pharmaceuticals Dysmenorrhea Treatment Major Product Offerings
        7.8.4 Mylan Pharmaceuticals Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.8.5 Mylan Pharmaceuticals Key News
    7.9 Nobel Pharmaceuticals
        7.9.1 Nobel Pharmaceuticals Corporate Summary
        7.9.2 Nobel Pharmaceuticals Business Overview
        7.9.3 Nobel Pharmaceuticals Dysmenorrhea Treatment Major Product Offerings
        7.9.4 Nobel Pharmaceuticals Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.9.5 Nobel Pharmaceuticals Key News
    7.10 Juniper Pharmaceuticals
        7.10.1 Juniper Pharmaceuticals Corporate Summary
        7.10.2 Juniper Pharmaceuticals Business Overview
        7.10.3 Juniper Pharmaceuticals Dysmenorrhea Treatment Major Product Offerings
        7.10.4 Juniper Pharmaceuticals Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.10.5 Juniper Pharmaceuticals Key News
    7.11 Sanofi
        7.11.1 Sanofi Corporate Summary
        7.11.2 Sanofi Business Overview
        7.11.3 Sanofi Dysmenorrhea Treatment Major Product Offerings
        7.11.4 Sanofi Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.11.5 Sanofi Key News
    7.12 GlaxoSmithKline
        7.12.1 GlaxoSmithKline Corporate Summary
        7.12.2 GlaxoSmithKline Business Overview
        7.12.3 GlaxoSmithKline Dysmenorrhea Treatment Major Product Offerings
        7.12.4 GlaxoSmithKline Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.12.5 GlaxoSmithKline Key News
    7.13 Johnson & Johnson
        7.13.1 Johnson & Johnson Corporate Summary
        7.13.2 Johnson & Johnson Business Overview
        7.13.3 Johnson & Johnson Dysmenorrhea Treatment Major Product Offerings
        7.13.4 Johnson & Johnson Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.13.5 Johnson & Johnson Key News
    7.14 Focus Consumer Healthcare
        7.14.1 Focus Consumer Healthcare Corporate Summary
        7.14.2 Focus Consumer Healthcare Business Overview
        7.14.3 Focus Consumer Healthcare Dysmenorrhea Treatment Major Product Offerings
        7.14.4 Focus Consumer Healthcare Dysmenorrhea Treatment Revenue in Global Market (2017-2022)
        7.14.5 Focus Consumer Healthcare Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Dysmenorrhea Treatment Market Opportunities & Trends in Global Market
    Table 2. Dysmenorrhea Treatment Market Drivers in Global Market
    Table 3. Dysmenorrhea Treatment Market Restraints in Global Market
    Table 4. Key Players of Dysmenorrhea Treatment in Global Market
    Table 5. Top Dysmenorrhea Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Dysmenorrhea Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Dysmenorrhea Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Dysmenorrhea Treatment Product Type
    Table 9. List of Global Tier 1 Dysmenorrhea Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Dysmenorrhea Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Dysmenorrhea Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Dysmenorrhea Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Dysmenorrhea Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Dysmenorrhea Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Dysmenorrhea Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Dysmenorrhea Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Dysmenorrhea Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Dysmenorrhea Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Dysmenorrhea Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Dysmenorrhea Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Dysmenorrhea Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Dysmenorrhea Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Dysmenorrhea Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Dysmenorrhea Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Merck & Co. Corporate Summary
    Table 31. Merck & Co. Dysmenorrhea Treatment Product Offerings
    Table 32. Merck & Co. Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis AG Corporate Summary
    Table 34. Novartis AG Dysmenorrhea Treatment Product Offerings
    Table 35. Novartis AG Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Bayer Corporate Summary
    Table 37. Bayer Dysmenorrhea Treatment Product Offerings
    Table 38. Bayer Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. Abbott Laboratories Corporate Summary
    Table 40. Abbott Laboratories Dysmenorrhea Treatment Product Offerings
    Table 41. Abbott Laboratories Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Pfizer Corporate Summary
    Table 43. Pfizer Dysmenorrhea Treatment Product Offerings
    Table 44. Pfizer Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Roche Corporate Summary
    Table 46. Roche Dysmenorrhea Treatment Product Offerings
    Table 47. Roche Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. TAJ Pharma Corporate Summary
    Table 49. TAJ Pharma Dysmenorrhea Treatment Product Offerings
    Table 50. TAJ Pharma Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Mylan Pharmaceuticals Corporate Summary
    Table 52. Mylan Pharmaceuticals Dysmenorrhea Treatment Product Offerings
    Table 53. Mylan Pharmaceuticals Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Nobel Pharmaceuticals Corporate Summary
    Table 55. Nobel Pharmaceuticals Dysmenorrhea Treatment Product Offerings
    Table 56. Nobel Pharmaceuticals Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 57. Juniper Pharmaceuticals Corporate Summary
    Table 58. Juniper Pharmaceuticals Dysmenorrhea Treatment Product Offerings
    Table 59. Juniper Pharmaceuticals Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 60. Sanofi Corporate Summary
    Table 61. Sanofi Dysmenorrhea Treatment Product Offerings
    Table 62. Sanofi Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 63. GlaxoSmithKline Corporate Summary
    Table 64. GlaxoSmithKline Dysmenorrhea Treatment Product Offerings
    Table 65. GlaxoSmithKline Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 66. Johnson & Johnson Corporate Summary
    Table 67. Johnson & Johnson Dysmenorrhea Treatment Product Offerings
    Table 68. Johnson & Johnson Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
    Table 69. Focus Consumer Healthcare Corporate Summary
    Table 70. Focus Consumer Healthcare Dysmenorrhea Treatment Product Offerings
    Table 71. Focus Consumer Healthcare Dysmenorrhea Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Dysmenorrhea Treatment Segment by Type in 2021
    Figure 2. Dysmenorrhea Treatment Segment by Application in 2021
    Figure 3. Global Dysmenorrhea Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Dysmenorrhea Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Dysmenorrhea Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Dysmenorrhea Treatment Revenue in 2021
    Figure 8. By Type - Global Dysmenorrhea Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Dysmenorrhea Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Dysmenorrhea Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Dysmenorrhea Treatment Revenue Market Share, 2017-2028
    Figure 12. US Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Dysmenorrhea Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Dysmenorrhea Treatment Revenue Market Share, 2017-2028
    Figure 24. China Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Dysmenorrhea Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Dysmenorrhea Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Dysmenorrhea Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Merck & Co. Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis AG Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Bayer Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Abbott Laboratories Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Pfizer Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Roche Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. TAJ Pharma Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Mylan Pharmaceuticals Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Nobel Pharmaceuticals Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Juniper Pharmaceuticals Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Sanofi Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. GlaxoSmithKline Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Johnson & Johnson Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Focus Consumer Healthcare Dysmenorrhea Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
69
Frequently Asked Questions
Dysmenorrhea Treatment Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dysmenorrhea Treatment Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dysmenorrhea Treatment Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports